“In the current environment, investment tends to be cautious. For start-ups with a long research and development cycle like ours, financing has become a big challenge. Fortunately, with the help of the Municipal Angel Fund, we have gained support in terms of funds and talents, and at the same time we have expanded our’ circle of friends’, which makes us more confident to take root in Ningbo and make achievements. ” A few days ago, Shang Xiaoyun, the head of Ningbo Maoxing Biomedical Technology Co., Ltd., said that the enterprise is applying for the “Yongjiang Talent Introduction Project”, and Ningbo Angel Fund has provided meticulous guidance services.
How to accurately serve the start-up technology-based enterprises so that enterprises have enough time to push technology to the forefront of the industry? In recent years, Ningbo Angel Investment Guidance Fund has anchored the development direction of Ningbo’s industry. While deeply excavating high-tech projects, it has invested “early” in “small” and “new” to cultivate a strong “reserve force” for Ningbo’s emerging industries. As of June this year, Ningbo Angel Investment Guidance Fund has exceeded 300 investment projects, of which the new generation information technology projects account for nearly half, and the proportion of life and health industry projects has increased year by year.
In February this year, Ningbo Maoxing Biomedical Technology Co., Ltd. was introduced to Ningbo, mainly engaged in the research and development and promotion of universal CAR-T therapy for brain tumors. In Shang Xiaoyun’s view, at present, the biggest problem facing enterprise development is the mismatch between development stage and development demand. “Technology, capital, talents and the growth of the company are complementary. Our company is in its infancy, and it is difficult to attract talents with international vision and level, but we are eager to have more funds and talents to further break through technology and become bigger and stronger. ”
The investment and guidance of angel fund has injected confidence into Maoxing Bio’s adherence to the track and devoted research. Recently, the company has obtained tens of millions of yuan in financing from angel investment institutions and Ningbo Angel Fund. After settling in Qianwan New District, the enterprise also “connected” with government departments under the matchmaking of the Municipal Angel Fund, and obtained many supports such as policy declaration and talent introduction. “In the future, with more technologies and products, we will expand our research field to the treatment of extracranial tumors and make contributions to the development of Ningbo biomedical industry.” Shang Xiaoyun said.
At present, with the vigorous growth of a number of enterprises, such as Huizhixing, Qunxinwei, Maoxing and Hengpu, the role of angel funds in strengthening the support of technology and finance in Ningbo has become more and more obvious. A few days ago, the “Implementation Opinions of the General Office of Ningbo Municipal People’s Government on Financial Support to Stimulate the Vitality of Market Subjects” was released, which explicitly mentioned supporting angel investment to guide the development of the fund and promoting the fund’s scale to 1 billion yuan.
“In the future, we will further expand the investment coverage of early projects, attract more professional investment institutions to support technology-based start-ups, build an early investment ecosystem in Ningbo, and inject more momentum into Ningbo’s scientific and technological innovation.” The relevant person in charge of Ningbo Angel Fund said.
(Source: Ningbo Science and Technology Bureau)